• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴结异常基因甲基化可为胃癌微转移的诊断提供一个可能的标志物。

Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.

机构信息

Department of Surgery, Saga University Faculty of Medicine, 5-1-1 Nabeshima, Saga, 849-8501, Japan.

出版信息

Ann Surg Oncol. 2010 Apr;17(4):1177-86. doi: 10.1245/s10434-009-0815-8. Epub 2009 Dec 3.

DOI:10.1245/s10434-009-0815-8
PMID:19957042
Abstract

BACKGROUND

This study was designed to determine whether gene methylation is a novel diagnostic marker for micrometastasis to the lymph nodes (LNs) in gastric cancer.

METHODS

The gene methylation of CHFR, p16, RUNX3, E-cadherin, MGMT, hMLH1, and ABCG2 genes were analyzed in 49 primary gastric cancer tissues, corresponding to noncancerous tissues and matched LNs by quantitative methylation-specific PCR (q-MSP).

RESULTS

CHFR, RUNX3, MGMT, and hMLH1 were more frequently methylated in primary cancer compared with the noncancerous mucosa. Further analyses investigated whether the methylation of the four cancer-specific genes was preserved in LN tissues using the 29 control cases, in which LN metastasis had been histologically confirmed. The methylation of both lesions (M/M pattern) in at least one gene, which was judged to be positive for cancer cells in LNs, was observed in 25 of 29 cases (86%). Quantitative RT-PCR (qRT-PCR) of CEA, CK19, and CK20 mRNA was conducted using the same samples. The mRNA expression of at least one of the three genes was observed in 100% of the specimens. The results of the control analysis were used to attempt to predict micrometastasis by q-MSP and qRT-PCR in the 20 test cases without histological LN metastasis. Six cases (30%) showed the M/M pattern in at least one of the four genes. Three of 20 cases (15%) exhibited both the M/M pattern and positive mRNA.

CONCLUSIONS

The methylation analysis revealed the clinical feasibility of detecting occult neoplastic cells in the regional LNs.

摘要

背景

本研究旨在确定基因甲基化是否是胃癌淋巴结微转移的新型诊断标志物。

方法

通过定量甲基化特异性 PCR(q-MSP)分析 49 例原发性胃癌组织及其对应的非癌组织和匹配的淋巴结中 CHFR、p16、RUNX3、E-钙黏蛋白、MGMT、hMLH1 和 ABCG2 基因的基因甲基化。

结果

与非癌性黏膜相比,CHFR、RUNX3、MGMT 和 hMLH1 在原发性癌症中更频繁地发生甲基化。进一步的分析使用 29 例经组织学证实有淋巴结转移的对照病例,研究了这四个癌症特异性基因的甲基化是否在淋巴结组织中得以保留。在至少一个基因中(M/M 模式),即判断为淋巴结中癌细胞阳性的两种病变的甲基化,在 29 例中的 25 例(86%)中观察到。使用相同的样本对 CEA、CK19 和 CK20 mRNA 进行了定量 RT-PCR(qRT-PCR)。在 100%的标本中观察到至少一种三种基因之一的 mRNA 表达。对照分析的结果用于尝试通过 q-MSP 和 qRT-PCR 在 20 例无组织学淋巴结转移的测试病例中预测微转移。在至少一个基因中显示 M/M 模式的有 6 例(30%)。在 20 例病例中,有 3 例(15%)同时出现 M/M 模式和阳性 mRNA。

结论

甲基化分析显示了在局部淋巴结中检测隐匿性肿瘤细胞的临床可行性。

相似文献

1
Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer.淋巴结异常基因甲基化可为胃癌微转移的诊断提供一个可能的标志物。
Ann Surg Oncol. 2010 Apr;17(4):1177-86. doi: 10.1245/s10434-009-0815-8. Epub 2009 Dec 3.
2
Promoter methylation of p16, Runx3, DAPK and CHFR genes is frequent in gastric carcinoma.p16、Runx3、DAPK和CHFR基因的启动子甲基化在胃癌中很常见。
Tumori. 2010 Sep-Oct;96(5):726-33. doi: 10.1177/030089161009600515.
3
Gene methylation in gastric cancer.胃癌中的基因甲基化。
Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10.
4
Aberrant DNA methylation of P16, MGMT, hMLH1 and hMSH2 genes in combination with the MTHFR C677T genetic polymorphism in gastric cancer.P16、MGMT、hMLH1和hMSH2基因的异常DNA甲基化与胃癌中MTHFR C677T基因多态性的联合研究
Asian Pac J Cancer Prev. 2013;14(5):3139-42. doi: 10.7314/apjcp.2013.14.5.3139.
5
Aberrant DNA methylation of MGMT and hMLH1 genes in prediction of gastric cancer.MGMT和hMLH1基因的异常DNA甲基化在胃癌预测中的作用
Genet Mol Res. 2014 May 30;13(2):4140-5. doi: 10.4238/2014.May.30.9.
6
Predictive value of CHFR and MLH1 methylation in human gastric cancer.CHFR和MLH1甲基化在人胃癌中的预测价值。
Gastric Cancer. 2015 Apr;18(2):280-7. doi: 10.1007/s10120-014-0370-2. Epub 2014 Apr 21.
7
[Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].[人胃腺癌中几种抑癌基因的启动子甲基化]
Zhonghua Yi Xue Za Zhi. 2007 Apr 10;87(14):978-81.
8
Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.早期胃腺癌及癌前病变中多个基因的启动子高甲基化
Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19.
9
Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.腹腔液中异常的基因甲基化是预测胃癌腹膜复发的危险因素。
World J Gastroenterol. 2010 Jan 21;16(3):330-8. doi: 10.3748/wjg.v16.i3.330.
10
Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.肝癌中 DNA 损伤反应基因的启动子高甲基化。
Cell Biol Int. 2012 May 1;36(5):427-32. doi: 10.1042/CBI20100851.

引用本文的文献

1
Runt-related Transcription Factor 3 Promoter Hypermethylation and Gastric Cancer Risk: A Meta-analysis.runt相关转录因子3启动子高甲基化与胃癌风险:一项Meta分析
Open Life Sci. 2018 Apr 10;13:64-70. doi: 10.1515/biol-2018-0009. eCollection 2018 Jan.
2
CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process.CHFR启动子高甲基化与胃癌相关,并在胃癌发生过程中发挥保护作用。
J Cancer. 2019 Jan 29;10(4):949-956. doi: 10.7150/jca.27224. eCollection 2019.
3
Epigenetic biomarkers of promoter DNA methylation in the new era of cancer treatment.
癌症治疗新时代的启动子 DNA 甲基化表观遗传生物标志物。
Cancer Sci. 2018 Dec;109(12):3695-3706. doi: 10.1111/cas.13812. Epub 2018 Oct 26.
4
Promoter Methylation and Prediction/Prognosis of Gastric Cancer: A Systematic Review and Meta and Bioinformatic Analysis.启动子甲基化与胃癌的预测/预后:一项系统评价及Meta分析和生物信息学分析
J Cancer. 2018 Apr 30;9(11):1932-1942. doi: 10.7150/jca.23284. eCollection 2018.
5
Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis.hMLH1启动子甲基化与胃癌风险的关联:一项Meta分析
Front Physiol. 2018 Apr 17;9:368. doi: 10.3389/fphys.2018.00368. eCollection 2018.
6
Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.表观遗传修饰作为肿瘤发生、治疗反应及癌症全程复发的生物标志物
Cancers (Basel). 2018 Apr 1;10(4):101. doi: 10.3390/cancers10040101.
7
Clinicopathological significance of promoter methylation in gastric cancer: a meta-analysis.胃癌中启动子甲基化的临床病理意义:一项荟萃分析。
Oncotarget. 2017 Dec 16;9(11):10083-10090. doi: 10.18632/oncotarget.23394. eCollection 2018 Feb 9.
8
Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis.MGMT基因启动子高甲基化可能与胃癌发病机制有关:一项符合PRISMA标准的荟萃分析。
Medicine (Baltimore). 2017 Apr;96(17):e6708. doi: 10.1097/MD.0000000000006708.
9
Association between gene hypermethylation and gastric cancer risk: a meta-analysis.基因高甲基化与胃癌风险之间的关联:一项荟萃分析。
Onco Targets Ther. 2016 Dec 8;9:7409-7414. doi: 10.2147/OTT.S118070. eCollection 2016.
10
The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis.胃癌中MGMT启动子甲基化与临床病理特征的相关性:一项系统评价与Meta分析
PLoS One. 2016 Nov 8;11(11):e0165509. doi: 10.1371/journal.pone.0165509. eCollection 2016.